2024
|
Invention
|
Recombinant lentiviral vector for stem cell-based gene therapy of sickle cell disorder.
This inv... |
|
Invention
|
Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation.
Metho... |
|
Invention
|
Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion.
Th... |
2023
|
Invention
|
Methods and kits of assessing status, risk or prognosis of type 1 diabetes.
The present inventio... |
2022
|
Invention
|
Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation.
The p... |
2021
|
Invention
|
Methods for predicting the survival time and treatment responsiveness of a patient suffering from... |
|
Invention
|
Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with... |
|
Invention
|
Analysis of eye movements in 3d real space in direction and depth. The invention relates to a met... |
2020
|
Invention
|
Digital biomolecules detection and/or quantification using isothermal amplification. The present ... |
|
Invention
|
Method of digital multiplex detection and/or quantification of biomolecules and use thereof. The ... |
|
Invention
|
Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment.
The p... |
|
Invention
|
Methods for the treatment of leber congenital amaurosis. The present invention relates to a metho... |
|
Invention
|
5-membered heteroaryl compounds containing a hydroxamate moiety and their use. The present invent... |
|
Invention
|
Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in s... |
2019
|
Invention
|
Combined use of selective serotonin reuptake inhibitors and hematopoietic growth factors for trea... |
|
Invention
|
Nanoparticles for preparing regulatory b cells. regregex vivoin vivoin vitroin vitro, was associa... |
|
Invention
|
Recombinant vectors suitable for the treatment of ipex syndrome. FOXP3FOXP3), which leads to the ... |
|
Invention
|
Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma... |
|
Invention
|
Methods for inducing full ablation of hematopoiesis. Conditioning regimens aiming at preparing a ... |
|
Invention
|
Urea derivatives for treating and/or preventing cancer. The present invention relates to a compou... |
|
Invention
|
Treatment of diseases associated with biliary system destruction. The present invention relates t... |
|
Invention
|
Device for quantifying dexterity. The invention relates to a device for quantifying the dexterity... |
|
Invention
|
Egfr inhibitors for treating keratodermas. Olmsted syndrome (OS) is a rare genodermatosis classic... |
|
Invention
|
Method to restore or improve cognitive functions. The present invention relates to the field of m... |
|
Invention
|
Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancy. FGFR3FGFR3 gain-o... |
|
Invention
|
Calibration standard for evanescence microscopy. The invention relates to a calibration standard ... |
|
Invention
|
Methods for increasing fetal hemoglobin content in eukaryotic cells and uses thereof for the trea... |
|
Invention
|
Methods for the treatment of neurofibromatosis. The invention relates to a PI3K inhibitor for use... |
|
Invention
|
Use of an inhibitor of ntsr1 activation or expression for preventing weight loss, muscle loss, an... |
|
Invention
|
Combination of her2/neu antibody with heme for treating cancer. The present invention relates to ... |
|
Invention
|
Preparation of nanosuspension comprising nanocrystals of active pharmaceutical ingredients with l... |
|
Invention
|
Methods and compositions for treating cancers. The invention relates to a method for treating can... |
|
Invention
|
Biocompatible tolerogenic nanoparticles. The present invention relates to nanoparticles, methods ... |
|
Invention
|
Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for... |
|
Invention
|
Methods and compositions for promoting wound healing in a subject suffering from ectodermal dyspl... |
|
Invention
|
Method for co-clustering senders and receivers based on text or image data files. 12M12DD), infer... |
|
Invention
|
Intravitreal delivery of a decorin polypeptide for the treatment of choroidal neovascularisation.... |
|
Invention
|
Electrochemical bioenzymatic sensor for measuring h2s in biological fluids. 222S in biological fl... |
|
Invention
|
Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia.
The presen... |
2018
|
Invention
|
Use of alpha-v-integrin (cd51) inhibitors for the treatment of cardiac fibrosis. Activated cardia... |
|
Invention
|
Methods and pharmaceutical compositions for the treatment of olmsted syndrome.
Olmsted syndrome ... |
|
Invention
|
Optical system for spatiotemporal shaping the wavefront of the electric field of an input light b... |
|
Invention
|
Methods and pharmaceutical compositions for inhibiting t cell proliferation in a subject in need ... |
|
Invention
|
Compounds, compositions and methods for treating insulin resistance. The invention relates to a c... |
|
Invention
|
Method for generating t cells progenitors.
The invention relates to an in vitro method to genera... |
|
Invention
|
Locomotion training device for infants |
2017
|
Invention
|
Multiparameter method for quantifying balance. A method for quantifying the balance of an individ... |
|
G/S
|
Downloadable computer software applications and software
[recorded programs]. Medical advice in ... |
|
G/S
|
Software [recorded programs] for analyzing data from
next-generation sequencing; computer progra... |
|
G/S
|
Downloadable computer software applications and software
[recorded programs] relating to remedia... |
|
G/S
|
Apparatus for analysis and diagnosis, not for medical use. Apparatus for developing motor skills ... |
|
Invention
|
Synthetic attc recombination sites for protein domain shuffling.
Recombinant nucleic acids compr... |
|
G/S
|
Appareils pour l'analyse et le diagnostic non à usage médical nommément appareils pour capter, en... |
|
Invention
|
Methods for the treatment of tissue lesions with ccr2 agonists. The present invention relates to ... |
2016
|
Invention
|
Factor h fragment for use as an anti-angiogenic agent.
The invention relates to a complement fac... |